The novel therapy of the medication represents a significant breakthrough in the management of type 2 diabetes. Different to existing medications, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide173659.tokka-blog.com/42449180/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment